ETRA — Electra Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual balance sheet for Electra Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 15.8 | 86.5 |
| Net Total Receivables | 0.055 | 0.22 |
| Prepaid Expenses | ||
| Total Current Assets | 19.4 | 95.5 |
| Net Property, Plant And Equipment | 0 | 2.78 |
| Other Long Term Assets | ||
| Total Assets | 19.4 | 99.4 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 4.2 | 9.73 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 4.2 | 11.2 |
| Redeemable Preferred Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 15.2 | 88.2 |
| Total Liabilities & Shareholders' Equity | 19.4 | 99.4 |
| Total Common Shares Outstanding |